High glucose exposure impairs L-cell differentiation in intestinal organoids: molecular mechanisms and clinical implications
In the brains of AD patients, a significant reduction in the expression of GLUT1, GLUT3, and GLUT4 was observed, impacting neuronal activity [61], progressive neuronal loss, and neurodegeneration [58, 62]
Shifting from rats to human clinical trials, Moussawi latest research focuses on the GLP-1 brenipatide, which is thought to target craving and drug use
The chromatographic peak area was quantified by the internal standard method (L-carnitine linear concentration range: 0.001 g/mL to 1,000 g/mL), and L-carnitine content greater than 500 mg/kg samples, only confirms the analysis
10.1039/c9sc01070j 72 XiangH.YouC.LiuW.WangD.ChenY.DongC